Chembio Diagnostics, Inc.
Hedge Funds Holdings
Last updated:
Chembio Diagnostics, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 2.6% of the total amount of its stocks outstanding. This makes up a total of 840.54K shares of Chembio Diagnostics, Inc.. Compared to the previous quarter, the number fell by -71.11% or -2.06M shares fewer. As for the holding position changes, 17.65% (3) of current hedge fund investors increased the number of shares held, 35.29% (6) of current holders sold a part of the shares held, and 58.82% (10) closed the holdings completely. 3 hedge funds are new holders of Chembio Diagnostics, Inc. stock in Q1 2023, it is 17.65% of total holders.
Hedge funds holding Chembio Diagnostics (Q2 2018 – Q1 2023)
| Q2 2018 | 32 |
|---|---|
| Q3 2018 | 32 |
| Q4 2018 | 42 |
| Q1 2019 | 39 |
| Q2 2019 | 38 |
| Q3 2019 | 44 |
| Q4 2019 | 38 |
| Q1 2020 | 41 |
| Q2 2020 | 75 |
| Q3 2020 | 60 |
| Q4 2020 | 76 |
| Q1 2021 | 71 |
| Q2 2021 | 58 |
| Q3 2021 | 46 |
| Q4 2021 | 41 |
| Q1 2022 | 33 |
| Q2 2022 | 34 |
| Q3 2022 | 30 |
| Q4 2022 | 35 |
| Q1 2023 | 17 |
Hedge funds changes in Chembio Diagnostics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 14 | 5 | 0 | 8 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 12 | 4 | 3 | 10 |
| Q4 2018 | 15 | 17 | 6 | 5 | -1 |
| Q1 2019 | 4 | 13 | 10 | 6 | 6 |
| Q2 2019 | 7 | 10 | 8 | 7 | 6 |
| Q3 2019 | 12 | 13 | 9 | 5 | 5 |
| Q4 2019 | 2 | 17 | 9 | 8 | 2 |
| Q1 2020 | 13 | 14 | 8 | 8 | -2 |
| Q2 2020 | 47 | 12 | 11 | 13 | -8 |
| Q3 2020 | 6 | 21 | 19 | 20 | -6 |
| Q4 2020 | 23 | 22 | 17 | 7 | 7 |
| Q1 2021 | 6 | 18 | 30 | 11 | 6 |
| Q2 2021 | 12 | 6 | 31 | 25 | -16 |
| Q3 2021 | 8 | 16 | 14 | 20 | -12 |
| Q4 2021 | 8 | 9 | 14 | 13 | -3 |
| Q1 2022 | 4 | 4 | 16 | 12 | -3 |
| Q2 2022 | 5 | 7 | 9 | 3 | 10 |
| Q3 2022 | 2 | 7 | 8 | 7 | 6 |
| Q4 2022 | 11 | 7 | 8 | 6 | 3 |
| Q1 2023 | 3 | 3 | 6 | 10 | -5 |
Hedge funds changes in Chembio Diagnostics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 795,000 | 803,000 |
| Q3 2020 | 2,221,000 | 2,129,000 |
| Q4 2020 | 1,393,000 | 2,488,000 |
| Q1 2021 | 634,000 | 646,000 |
| Q2 2021 | 409,000 | 556,000 |
| Q3 2021 | 1,043,000 | 2,001,000 |
| Q4 2021 | 106,000 | 298,000 |
| Q1 2022 | 53,000 | 116,000 |
| Q2 2022 | 28,000 | 50,000 |
| Q3 2022 | 38,000 | 5,000 |
| Q4 2022 | 16,900 | 5,527 |
| Q1 2023 | 45,000 | 3,000 |